Technical Analysis for XOMAP - XOMA Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 25.73 | 0.16% | 0.04 |
XOMAP closed up 0.16 percent on Friday, November 22, 2024, on 63 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | 0.16% | |
Oversold Stochastic | Weakness | 0.16% | |
Fell Below 50 DMA | Bearish | 0.16% | |
Narrow Range Bar | Range Contraction | 0.16% | |
Stochastic Reached Oversold | Weakness | 0.16% | |
Gapped Down | Weakness | 0.16% | |
Oversold Stochastic | Weakness | 0.16% |
Alert | Time |
---|---|
50 DMA Resistance | 2 days ago |
20 DMA Resistance | 2 days ago |
10 DMA Resistance | 2 days ago |
Rose Above 20 DMA | 2 days ago |
Rose Above Previous Day's High | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.
Keywords: Biotechnology
Classification
Keywords: Biotechnology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 26.51 |
52 Week Low | 20.3265 |
Average Volume | 1,840 |
200-Day Moving Average | 24.66 |
50-Day Moving Average | 25.85 |
20-Day Moving Average | 25.95 |
10-Day Moving Average | 25.79 |
Average True Range | 0.21 |
RSI (14) | 45.65 |
ADX | 12.19 |
+DI | 32.37 |
-DI | 27.45 |
Chandelier Exit (Long, 3 ATRs) | 25.88 |
Chandelier Exit (Short, 3 ATRs) | 26.31 |
Upper Bollinger Bands | 26.50 |
Lower Bollinger Band | 25.40 |
Percent B (%b) | 0.3 |
BandWidth | 4.24 |
MACD Line | -0.05 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0405 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 26.00 | ||||
Resistance 3 (R3) | 26.03 | 25.96 | 25.96 | ||
Resistance 2 (R2) | 25.96 | 25.89 | 25.95 | 25.94 | |
Resistance 1 (R1) | 25.85 | 25.85 | 25.82 | 25.82 | 25.92 |
Pivot Point | 25.78 | 25.78 | 25.77 | 25.77 | 25.78 |
Support 1 (S1) | 25.67 | 25.71 | 25.64 | 25.64 | 25.54 |
Support 2 (S2) | 25.60 | 25.67 | 25.59 | 25.52 | |
Support 3 (S3) | 25.49 | 25.60 | 25.51 | ||
Support 4 (S4) | 25.46 |